Insider filing · KYMR
Kymera Therapeutics, Inc.
KYMR · Healthcare · 58 filings in 24 months
ticker →
Biotechnology Value Fund Ii Lp sold $173.7M of Kymera Therapeutics (KYMR)
Executed Jun 26, disclosed Jun 26, the same day.
Value, as filed
$173.7M
1,630,658 sh across 4 lots
Executed
Jun 26
the trade date, as filed
Disclosed
Jun 26
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
BL
Biotechnology Value Fund Ii Lp
Director
profile →
Biotechnology Value Fund Ii Lp (Director) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $173.7M of KYMR (1,630,658 sh across 4 lots, as filed), executed Jun 26.
The name
KYMRHealthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→